News

It is also important for motor function, and when it disappears from some regions of the brain, it can cause Parkinson’s disease. That is why levodopa, which our body metabolizes to make dopamine, ...
Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...
New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...
The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.
Dopamine in the brain in other respects it is easy to see how a Parkinson’s patient could also suffer from unusual symptoms. In fact, over 50% of Parkinson’s patients suffer from Parkinson’s ...
Challenging Parkinson's dogma: Dopamine may not be the only key player in this tragic neurodegenerative disease. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2012 ...
People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...
A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects.. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness ...
Transplantation of human embryonic dopamine neurons into the brains of patients with Parkinson's disease has proved beneficial in open clinical trials. However, whether this intervention would be ...
A new drug is showing promise in treating Parkinson’s while reducing unwanted side effects. The pill, tavapadon, extended symptom relief without the adverse effects of the first line of treatment.